Is a preoperative pathogen detection a prerequisite before undergoing one-stage exchange for prosthetic joint infection of the hip?


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 31 12 2021
accepted: 16 04 2022
medline: 19 5 2023
pubmed: 5 5 2022
entrez: 4 5 2022
Statut: ppublish

Résumé

A preoperative pathogen detection is considered a prerequisite before undergoing one-stage exchange for prosthetic joint infection (PJI) according to most guidelines. This study compares patients with and without preoperative pathogen detection undergoing one-stage exchange for PJI of the hip. The authors put up the hypothesis that a preoperative pathogen detection is no prerequisite in selected cases undergoing one-stage exchange. 30 consecutive patients with PJI of the hip, treated with one-stage exchange, between 2011 and 2021, were retrospectively included. Mean age was 70 years and mean follow-up 2.1 ± 1.8 years. PJI was defined according to the European Bone and Joint Infection Society. One-stage exchange was performed in (1) chronic PJI longer than 4 weeks, (2) well-retained bone condition, (3) absence of multiple prior revisions for PJI (≤ 2) with absence of difficult-to-treat pathogens in the past, and (4) necessity/preference for early mobility due to comorbidities/age. One-stage exchange was performed in 20 patients with and in 10 without a preoperative pathogen detection. Age (71 years, 68 years, p = 0.519), sex (50% and 30% males, p = 0.440), American Society of Anesthesiologists Score (2.2, 2.4, p = 0.502), and Charlson Comorbidity Index (3, 4, p = 0.530) did not differ among the two groups. No significant differences were noted concerning preoperative CRP (15 mg/l, 43 mg/l, p = 0.228), synovial cell count (15.990/nl, 5.308/nl, p = 0.887), radiological signs of loosening (55%, 50%, p = 0.999), and intraoperative histopathology. Except a higher rate of coagulase-negative staphylococci (70%, 20%, p = 0.019) in patients with a preoperative pathogen detection, no significant differences in pathogen spectrum were identified among groups. Revision for PJI recurrence was performed in one patient with an initial preoperative pathogen detection (3.3%). Additional revisions were performed for dislocation in two and postoperative hematoma in one patient. Revision rate for both septic and aseptic causes (p = 0.999), stay in hospital (16 and 15 days, p = 0.373) and modified Harris Hip Score (60, 71, p = 0.350) did not differ between groups. Patients with and without a preoperative pathogen detection did not show significant differences concerning baseline characteristics, clinical and functional outcomes at 2 years. An absent preoperative pathogen detection is no absolute contraindication for one-stage exchange in chronic PJI, if involving good bone quality and absence of multiple prior revisions.

Sections du résumé

BACKGROUND BACKGROUND
A preoperative pathogen detection is considered a prerequisite before undergoing one-stage exchange for prosthetic joint infection (PJI) according to most guidelines. This study compares patients with and without preoperative pathogen detection undergoing one-stage exchange for PJI of the hip. The authors put up the hypothesis that a preoperative pathogen detection is no prerequisite in selected cases undergoing one-stage exchange.
METHODS METHODS
30 consecutive patients with PJI of the hip, treated with one-stage exchange, between 2011 and 2021, were retrospectively included. Mean age was 70 years and mean follow-up 2.1 ± 1.8 years. PJI was defined according to the European Bone and Joint Infection Society. One-stage exchange was performed in (1) chronic PJI longer than 4 weeks, (2) well-retained bone condition, (3) absence of multiple prior revisions for PJI (≤ 2) with absence of difficult-to-treat pathogens in the past, and (4) necessity/preference for early mobility due to comorbidities/age.
RESULTS RESULTS
One-stage exchange was performed in 20 patients with and in 10 without a preoperative pathogen detection. Age (71 years, 68 years, p = 0.519), sex (50% and 30% males, p = 0.440), American Society of Anesthesiologists Score (2.2, 2.4, p = 0.502), and Charlson Comorbidity Index (3, 4, p = 0.530) did not differ among the two groups. No significant differences were noted concerning preoperative CRP (15 mg/l, 43 mg/l, p = 0.228), synovial cell count (15.990/nl, 5.308/nl, p = 0.887), radiological signs of loosening (55%, 50%, p = 0.999), and intraoperative histopathology. Except a higher rate of coagulase-negative staphylococci (70%, 20%, p = 0.019) in patients with a preoperative pathogen detection, no significant differences in pathogen spectrum were identified among groups. Revision for PJI recurrence was performed in one patient with an initial preoperative pathogen detection (3.3%). Additional revisions were performed for dislocation in two and postoperative hematoma in one patient. Revision rate for both septic and aseptic causes (p = 0.999), stay in hospital (16 and 15 days, p = 0.373) and modified Harris Hip Score (60, 71, p = 0.350) did not differ between groups.
CONCLUSION CONCLUSIONS
Patients with and without a preoperative pathogen detection did not show significant differences concerning baseline characteristics, clinical and functional outcomes at 2 years. An absent preoperative pathogen detection is no absolute contraindication for one-stage exchange in chronic PJI, if involving good bone quality and absence of multiple prior revisions.

Identifiants

pubmed: 35508548
doi: 10.1007/s00402-022-04459-5
pii: 10.1007/s00402-022-04459-5
pmc: PMC10191905
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2823-2830

Informations de copyright

© 2022. The Author(s).

Références

J Arthroplasty. 2021 May;36(5):1758-1764
pubmed: 33267978
Bone Joint J. 2019 Jan;101-B(1_Supple_A):19-24
pubmed: 30648487
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
Bone Joint J. 2021 Mar;103-B(3):515-521
pubmed: 33455434
Clin Infect Dis. 2013 Jan;56(1):1-10
pubmed: 23230301
Bone Joint J. 2021 Jan;103-B(1):18-25
pubmed: 33380199
J Arthroplasty. 2018 May;33(5):1309-1314.e2
pubmed: 29551303
Clin Orthop Relat Res. 2015 Jan;473(1):8-14
pubmed: 24923669
Int Orthop. 2016 May;40(5):913-8
pubmed: 26224611
Int Orthop. 2018 May;42(5):983-994
pubmed: 29523955
Hip Pelvis. 2018 Sep;30(3):138-146
pubmed: 30202747
Bone Joint J. 2013 Nov;95-B(11 Suppl A):77-83
pubmed: 24187359
BMC Musculoskelet Disord. 2021 Sep 12;22(1):780
pubmed: 34511107
J Arthroplasty. 2013 Sep;28(8 Suppl):66-70
pubmed: 23972299
Bone Joint J. 2014 Apr;96-B(4):492-6
pubmed: 24692616
J Arthroplasty. 2018 Apr;33(4):1160-1165.e1
pubmed: 29221839
Expert Rev Med Devices. 2020 Mar;17(3):245-252
pubmed: 32098518
Orthop Traumatol Surg Res. 2016 Feb;102(1):127-9
pubmed: 26611716
Arch Orthop Trauma Surg. 2018 May;138(5):635-642
pubmed: 29352435
J Arthroplasty. 2014 May;29(5):1076-81
pubmed: 24332970
Curr Rev Musculoskelet Med. 2018 Sep;11(3):370-379
pubmed: 29987643
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
Clin Orthop Relat Res. 2022 May 1;480(5):905-914
pubmed: 34851871
J Bone Joint Surg Am. 2011 Apr 6;93(7):631-9
pubmed: 21471416
J Orthop Res. 2014 Jan;32 Suppl 1:S141-6
pubmed: 24464888
PLoS One. 2015 Sep 25;10(9):e0139166
pubmed: 26407003
J Arthroplasty. 2017 Sep;32(9S):S59-S62
pubmed: 28302460
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
EFORT Open Rev. 2019 Jul 29;4(7):482-494
pubmed: 31423332
Int Orthop. 2022 Mar;46(3):449-456
pubmed: 34783888
Pathol Res Pract. 2014 Dec;210(12):779-86
pubmed: 25454771
Bone Joint J. 2019 Apr;101-B(4):396-402
pubmed: 30929477
Orthop Traumatol Surg Res. 2021 Jun;107(4):102668
pubmed: 32798125

Auteurs

Daniel Karczewski (D)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. daniel.karczewski@charite.de.

Yannick Seutz (Y)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Christian Hipfl (C)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Doruk Akgün (D)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Octavian Andronic (O)

Orthopedic Surgery, Balgrist University Hospital, Forchstrasse 340, CH-8008, Zurich, Switzerland.

Carsten Perka (C)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Sebastian Hardt (S)

Center for Musculoskeletal Surgery, Department of Orthopaedic Surgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH